位置:首页 > 蛋白库 > NR3L1_HUMAN
NR3L1_HUMAN
ID   NR3L1_HUMAN             Reviewed;         454 AA.
AC   Q68D85; Q7Z3M6;
DT   19-JAN-2010, integrated into UniProtKB/Swiss-Prot.
DT   11-OCT-2004, sequence version 1.
DT   03-AUG-2022, entry version 149.
DE   RecName: Full=Natural cytotoxicity triggering receptor 3 ligand 1;
DE   AltName: Full=B7 homolog 6;
DE            Short=B7-H6;
DE   Flags: Precursor;
GN   Name=NCR3LG1; Synonyms=B7H6;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Uterine endothelium;
RX   PubMed=17974005; DOI=10.1186/1471-2164-8-399;
RA   Bechtel S., Rosenfelder H., Duda A., Schmidt C.P., Ernst U.,
RA   Wellenreuther R., Mehrle A., Schuster C., Bahr A., Bloecker H., Heubner D.,
RA   Hoerlein A., Michel G., Wedler H., Koehrer K., Ottenwaelder B., Poustka A.,
RA   Wiemann S., Schupp I.;
RT   "The full-ORF clone resource of the German cDNA consortium.";
RL   BMC Genomics 8:399-399(2007).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16554811; DOI=10.1038/nature04632;
RA   Taylor T.D., Noguchi H., Totoki Y., Toyoda A., Kuroki Y., Dewar K.,
RA   Lloyd C., Itoh T., Takeda T., Kim D.-W., She X., Barlow K.F., Bloom T.,
RA   Bruford E., Chang J.L., Cuomo C.A., Eichler E., FitzGerald M.G.,
RA   Jaffe D.B., LaButti K., Nicol R., Park H.-S., Seaman C., Sougnez C.,
RA   Yang X., Zimmer A.R., Zody M.C., Birren B.W., Nusbaum C., Fujiyama A.,
RA   Hattori M., Rogers J., Lander E.S., Sakaki Y.;
RT   "Human chromosome 11 DNA sequence and analysis including novel gene
RT   identification.";
RL   Nature 440:497-500(2006).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Cerebellum;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [4]
RP   FUNCTION, INTERACTION WITH NCR3, SUBCELLULAR LOCATION, AND TISSUE
RP   SPECIFICITY.
RX   PubMed=19528259; DOI=10.1084/jem.20090681;
RA   Brandt C.S., Baratin M., Yi E.C., Kennedy J., Gao Z., Fox B., Haldeman B.,
RA   Ostrander C.D., Kaifu T., Chabannon C., Moretta A., West R., Xu W.,
RA   Vivier E., Levin S.D.;
RT   "The B7 family member B7-H6 is a tumor cell ligand for the activating
RT   natural killer cell receptor NKp30 in humans.";
RL   J. Exp. Med. 206:1495-1503(2009).
RN   [5]
RP   X-RAY CRYSTALLOGRAPHY (2.0 ANGSTROMS) OF 25-262 ALONE AND IN COMPLEX WITH
RP   NCR3, GLYCOSYLATION AT ASN-43; ASN-57; ASN-208 AND ASN-242, SUBUNIT, AND
RP   DISULFIDE BONDS.
RX   PubMed=21422170; DOI=10.1084/jem.20102548;
RA   Li Y., Wang Q., Mariuzza R.A.;
RT   "Structure of the human activating natural cytotoxicity receptor NKp30
RT   bound to its tumor cell ligand B7-H6.";
RL   J. Exp. Med. 208:703-714(2011).
CC   -!- FUNCTION: Triggers NCR3-dependent natural killer cell activation.
CC       {ECO:0000269|PubMed:19528259}.
CC   -!- SUBUNIT: Monomer. Interacts specifically with NCR3, but not with other
CC       natural killer cell-activating receptors, including NCR1, NCR2 and
CC       KLRK1. {ECO:0000269|PubMed:19528259, ECO:0000269|PubMed:21422170}.
CC   -!- INTERACTION:
CC       Q68D85; P29400-2: COL4A5; NbExp=3; IntAct=EBI-14061804, EBI-12211159;
CC       Q68D85; Q9UKR5: ERG28; NbExp=3; IntAct=EBI-14061804, EBI-711490;
CC       Q68D85; O14931: NCR3; NbExp=16; IntAct=EBI-14061804, EBI-14989262;
CC       Q68D85; Q8N912: NRAC; NbExp=3; IntAct=EBI-14061804, EBI-12051377;
CC       Q68D85; Q8IY26: PLPP6; NbExp=3; IntAct=EBI-14061804, EBI-11721828;
CC       Q68D85; Q9UNK0: STX8; NbExp=3; IntAct=EBI-14061804, EBI-727240;
CC       Q68D85; Q9P0S9: TMEM14C; NbExp=3; IntAct=EBI-14061804, EBI-2339195;
CC       Q68D85; Q9H0R3: TMEM222; NbExp=3; IntAct=EBI-14061804, EBI-347385;
CC       Q68D85; P30536: TSPO; NbExp=3; IntAct=EBI-14061804, EBI-6623146;
CC       Q68D85; Q5BVD1: TTMP; NbExp=3; IntAct=EBI-14061804, EBI-10243654;
CC   -!- SUBCELLULAR LOCATION: Cell membrane {ECO:0000269|PubMed:19528259};
CC       Single-pass type I membrane protein {ECO:0000269|PubMed:19528259}.
CC   -!- TISSUE SPECIFICITY: Not detected in any normal tissue tested. Expressed
CC       at the surface of several tumor cell lines including T and B-lymphomas,
CC       myeloid leukemias, melanomas, carcinomas and large T SV40 antigen-
CC       transformed cells (at protein level). {ECO:0000269|PubMed:19528259}.
CC   -!- DOMAIN: The C-terminal part is similar to retroviral Gag protein. This
CC       putative protein seems to be the result of a fusion between an Ig-like
CC       domain-containing protein and a ERV.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=CAD97811.1; Type=Erroneous initiation; Note=Extended N-terminus.; Evidence={ECO:0000305};
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; BX537685; CAD97811.1; ALT_INIT; mRNA.
DR   EMBL; CR749521; CAH18335.1; -; mRNA.
DR   EMBL; AC124798; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC136800; -; NOT_ANNOTATED_CDS; mRNA.
DR   EMBL; BC136797; -; NOT_ANNOTATED_CDS; mRNA.
DR   CCDS; CCDS55748.1; -.
DR   RefSeq; NP_001189368.1; NM_001202439.2.
DR   PDB; 3PV6; X-ray; 2.30 A; A=25-262.
DR   PDB; 3PV7; X-ray; 2.00 A; A=25-262.
DR   PDB; 4ZSO; X-ray; 2.50 A; E/F=25-262.
DR   PDB; 6YJP; X-ray; 3.10 A; C/D/E=24-244.
DR   PDBsum; 3PV6; -.
DR   PDBsum; 3PV7; -.
DR   PDBsum; 4ZSO; -.
DR   PDBsum; 6YJP; -.
DR   AlphaFoldDB; Q68D85; -.
DR   SMR; Q68D85; -.
DR   BioGRID; 131895; 64.
DR   DIP; DIP-59940N; -.
DR   IntAct; Q68D85; 39.
DR   STRING; 9606.ENSP00000341637; -.
DR   GlyConnect; 642; 2 N-Linked glycans (2 sites).
DR   GlyGen; Q68D85; 7 sites, 2 N-linked glycans (2 sites).
DR   iPTMnet; Q68D85; -.
DR   PhosphoSitePlus; Q68D85; -.
DR   BioMuta; NCR3LG1; -.
DR   DMDM; 74708829; -.
DR   EPD; Q68D85; -.
DR   jPOST; Q68D85; -.
DR   MassIVE; Q68D85; -.
DR   MaxQB; Q68D85; -.
DR   PaxDb; Q68D85; -.
DR   PeptideAtlas; Q68D85; -.
DR   PRIDE; Q68D85; -.
DR   ProteomicsDB; 66058; -.
DR   ABCD; Q68D85; 1 sequenced antibody.
DR   Antibodypedia; 6152; 388 antibodies from 21 providers.
DR   DNASU; 374383; -.
DR   Ensembl; ENST00000338965.9; ENSP00000341637.4; ENSG00000188211.9.
DR   Ensembl; ENST00000530403.1; ENSP00000434394.1; ENSG00000188211.9.
DR   GeneID; 374383; -.
DR   KEGG; hsa:374383; -.
DR   MANE-Select; ENST00000338965.9; ENSP00000341637.4; NM_001202439.3; NP_001189368.1.
DR   UCSC; uc001mmz.5; human.
DR   CTD; 374383; -.
DR   DisGeNET; 374383; -.
DR   GeneCards; NCR3LG1; -.
DR   HGNC; HGNC:42400; NCR3LG1.
DR   HPA; ENSG00000188211; Tissue enhanced (parathyroid).
DR   MIM; 613714; gene.
DR   neXtProt; NX_Q68D85; -.
DR   OpenTargets; ENSG00000188211; -.
DR   VEuPathDB; HostDB:ENSG00000188211; -.
DR   eggNOG; KOG3866; Eukaryota.
DR   GeneTree; ENSGT00940000163348; -.
DR   HOGENOM; CLU_602620_0_0_1; -.
DR   InParanoid; Q68D85; -.
DR   OMA; GKYMCES; -.
DR   OrthoDB; 1030784at2759; -.
DR   PhylomeDB; Q68D85; -.
DR   TreeFam; TF331083; -.
DR   PathwayCommons; Q68D85; -.
DR   Reactome; R-HSA-198933; Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell.
DR   SignaLink; Q68D85; -.
DR   BioGRID-ORCS; 374383; 17 hits in 1075 CRISPR screens.
DR   EvolutionaryTrace; Q68D85; -.
DR   GenomeRNAi; 374383; -.
DR   Pharos; Q68D85; Tbio.
DR   PRO; PR:Q68D85; -.
DR   Proteomes; UP000005640; Chromosome 11.
DR   RNAct; Q68D85; protein.
DR   Bgee; ENSG00000188211; Expressed in cerebellar vermis and 100 other tissues.
DR   Genevisible; Q68D85; HS.
DR   GO; GO:0016021; C:integral component of membrane; IEA:UniProtKB-KW.
DR   GO; GO:0005886; C:plasma membrane; TAS:Reactome.
DR   GO; GO:0003823; F:antigen binding; IBA:GO_Central.
DR   GO; GO:0050776; P:regulation of immune response; IBA:GO_Central.
DR   Gene3D; 1.10.150.180; -; 1.
DR   Gene3D; 2.60.40.10; -; 2.
DR   InterPro; IPR036946; G_retro_matrix_sf.
DR   InterPro; IPR007110; Ig-like_dom.
DR   InterPro; IPR036179; Ig-like_dom_sf.
DR   InterPro; IPR013783; Ig-like_fold.
DR   InterPro; IPR003006; Ig/MHC_CS.
DR   InterPro; IPR003597; Ig_C1-set.
DR   InterPro; IPR003599; Ig_sub.
DR   InterPro; IPR010999; Retrovr_matrix.
DR   Pfam; PF07654; C1-set; 1.
DR   SMART; SM00409; IG; 1.
DR   SMART; SM00407; IGc1; 1.
DR   SUPFAM; SSF47836; SSF47836; 1.
DR   SUPFAM; SSF48726; SSF48726; 2.
DR   PROSITE; PS50835; IG_LIKE; 2.
DR   PROSITE; PS00290; IG_MHC; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Cell membrane; Disulfide bond; Glycoprotein;
KW   Immunoglobulin domain; Membrane; Reference proteome; Repeat; Signal;
KW   Transmembrane; Transmembrane helix.
FT   SIGNAL          1..24
FT                   /evidence="ECO:0000255"
FT   CHAIN           25..454
FT                   /note="Natural cytotoxicity triggering receptor 3 ligand 1"
FT                   /id="PRO_0000390564"
FT   TOPO_DOM        25..262
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        263..283
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        284..454
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   DOMAIN          27..138
FT                   /note="Ig-like V-type"
FT   DOMAIN          143..244
FT                   /note="Ig-like C1-type"
FT   REGION          59..62
FT                   /note="Interaction with NCR3"
FT                   /evidence="ECO:0000269|PubMed:19528259"
FT   REGION          127..130
FT                   /note="Interaction with NCR3"
FT                   /evidence="ECO:0000269|PubMed:19528259"
FT   REGION          291..429
FT                   /note="Retroviral-Gag-like"
FT   REGION          395..454
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        400..414
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        435..454
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   CARBOHYD        43
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000269|PubMed:21422170"
FT   CARBOHYD        57
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000269|PubMed:21422170"
FT   CARBOHYD        174
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        208
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000269|PubMed:21422170"
FT   CARBOHYD        216
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        242
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000269|PubMed:21422170"
FT   CARBOHYD        260
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   DISULFID        48..122
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00114,
FT                   ECO:0000269|PubMed:21422170"
FT   DISULFID        163..228
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00114,
FT                   ECO:0000269|PubMed:21422170"
FT   CONFLICT        37
FT                   /note="I -> V (in Ref. 1; CAD97811)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        211
FT                   /note="S -> N (in Ref. 1; CAD97811)"
FT                   /evidence="ECO:0000305"
FT   STRAND          26..29
FT                   /evidence="ECO:0007829|PDB:3PV7"
FT   STRAND          34..39
FT                   /evidence="ECO:0007829|PDB:3PV7"
FT   STRAND          44..46
FT                   /evidence="ECO:0007829|PDB:3PV7"
FT   STRAND          49..54
FT                   /evidence="ECO:0007829|PDB:3PV7"
FT   HELIX           58..60
FT                   /evidence="ECO:0007829|PDB:3PV6"
FT   STRAND          62..68
FT                   /evidence="ECO:0007829|PDB:3PV7"
FT   STRAND          70..73
FT                   /evidence="ECO:0007829|PDB:3PV6"
FT   STRAND          75..84
FT                   /evidence="ECO:0007829|PDB:3PV7"
FT   STRAND          86..90
FT                   /evidence="ECO:0007829|PDB:3PV7"
FT   HELIX           97..100
FT                   /evidence="ECO:0007829|PDB:3PV7"
FT   TURN            101..103
FT                   /evidence="ECO:0007829|PDB:3PV7"
FT   STRAND          107..111
FT                   /evidence="ECO:0007829|PDB:3PV7"
FT   HELIX           114..116
FT                   /evidence="ECO:0007829|PDB:3PV7"
FT   STRAND          118..126
FT                   /evidence="ECO:0007829|PDB:3PV7"
FT   STRAND          129..141
FT                   /evidence="ECO:0007829|PDB:3PV7"
FT   STRAND          144..148
FT                   /evidence="ECO:0007829|PDB:3PV7"
FT   STRAND          156..158
FT                   /evidence="ECO:0007829|PDB:6YJP"
FT   STRAND          160..171
FT                   /evidence="ECO:0007829|PDB:3PV7"
FT   STRAND          174..180
FT                   /evidence="ECO:0007829|PDB:3PV7"
FT   STRAND          182..184
FT                   /evidence="ECO:0007829|PDB:3PV7"
FT   STRAND          188..190
FT                   /evidence="ECO:0007829|PDB:3PV7"
FT   STRAND          194..201
FT                   /evidence="ECO:0007829|PDB:3PV7"
FT   STRAND          207..214
FT                   /evidence="ECO:0007829|PDB:3PV7"
FT   HELIX           217..219
FT                   /evidence="ECO:0007829|PDB:4ZSO"
FT   STRAND          225..231
FT                   /evidence="ECO:0007829|PDB:3PV7"
FT   STRAND          239..243
FT                   /evidence="ECO:0007829|PDB:3PV7"
SQ   SEQUENCE   454 AA;  50827 MW;  433CE0B0EE0A4470 CRC64;
     MTWRAAASTC AALLILLWAL TTEGDLKVEM MAGGTQITPL NDNVTIFCNI FYSQPLNITS
     MGITWFWKSL TFDKEVKVFE FFGDHQEAFR PGAIVSPWRL KSGDASLRLP GIQLEEAGEY
     RCEVVVTPLK AQGTVQLEVV ASPASRLLLD QVGMKENEDK YMCESSGFYP EAINITWEKQ
     TQKFPHPIEI SEDVITGPTI KNMDGTFNVT SCLKLNSSQE DPGTVYQCVV RHASLHTPLR
     SNFTLTAARH SLSETEKTDN FSIHWWPISF IGVGLVLLIV LIPWKKICNK SSSAYTPLKC
     ILKHWNSFDT QTLKKEHLIF FCTRAWPSYQ LQDGEAWPPE GSVNINTIQQ LDVFCRQEGK
     WSEVPYVQAF FALRDNPDLC QCCRIDPALL TVTSGKSIDD NSTKSEKQTP REHSDAVPDA
     PILPVSPIWE PPPATTSTTP VLSSQPPTLL LPLQ
 
 
维奥蛋白资源库 - 中文蛋白资源 CopyRight © 2010-2024